Commonwealth Health’s latest addition in the fight against cancer is a new robotic-assisted platform that enables doctors to perform minimally invasive lung biopsies – navigational bronchoscopy.

Robotic-assisted navigational bronchoscopy allows the specialist to use natural openings in the body, like the mouth, and substantially decreases risk of collapsing the lung. Compared to previous navigational bronchoscopy platforms, the flexibility and shape-sensing capabilities of the catheter increase diagnostic capabilities, enabling a more precise biopsy.

When used with lung cancer screening, this technology supports early diagnosis and staging of the lung cancer, often with just one minimally invasive procedure.

Robotic-assisted navigational bronchoscopy benefits:

• Minimally invasive method for lung biopsies
• Ability to biopsy nodules previously inaccessible
• Capacity to catch lung cancer at an earlier stage, resulting in improved outcomes and survival rates

This technology is only available locally at Regional Hospital of Scranton. For more information, call 570-770-LUNG.